Research reveals medicine of his spit of fland helps to treat pyemiapyaemia and lung to damage
Research reveals medicine of his spit of fland helps to treat pyemiapyaemia and lung to damage
Washington, May 4 (Xinhuanet) ' Reporter Ren HaiJun) The research report that the researchers of Lund University of Swedish announced a few days ago is called, it contributes to treating pyemiapyaemia and lungs caused to damage too to usually use as lowering his spit of fland medicine of cholesterol. Researchers have fostered two groups of pyemiapyaemia and caused the acute lung to damage the experimental mouse, one of these group is cut down the treatment of his spit of fland hard by his spit of fland medicine, and the control group only drinks water. Researchers find, it is accepted that the hard experiment mouse's lung which cuts down treatment of his spit of fland damages the intensity and is smaller than the control group far. In addition, the is infected with cells and causes materials infected to be less ing of the former's lung. The researcher thinks, these discoveries prove, the treatment of his spit of fland will probably have clinical value to the serious pyemiapyaemia patient. This result of study has already been published on the 5th of U.S.A. " biological magazine of leucocyte ". The comment of this magazine thinks, pyemiapyaemia is less medical difficult problems of treatment means, the above-mentioned research results are very exciting, medicine of his spit of fland has been already used widely at present, tolerance is better, in the course of treating pyemiapyaemia, can regard medicine of his spit of fland as candidate medicine, test its curative effect to this disease. Pyemiapyaemia is syndrome that inflammation reacts all over caused by infecting, the fatality rates is relatively high. U.S.A. have 75 people Wan suffer from pyemiapyaemia nearly every year, among them about half the die, exceed country this die of the intersection of prostate and cancer, breast carcinoma and patient of AIDS the sum of every year.
|
No comments:
Post a Comment